Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.
AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.
The announcement will come as welcome news, as nuclear medicine departments in numerous regions have been grappling with shortages of Mo-99 and Tc-99m.
Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
